Overview
Aleva Neurotherapeutics is a Swiss medical device company developing directional deep brain stimulation leads for Parkinson's disease and other movement disorders. Their directSTIM technology enables highly targeted stimulation to maximize therapeutic benefit while minimizing side effects.
More in Brain-Computer Interfaces
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
🧠 Brain-Computer Interfaces
Location
Lausanne, Switzerland
Funding
Series C · $35M
Website
aleva-neuro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →